In a patient who is not eating, barely drinking, and speaking minimally, should we administer lorazepam (Ativan)?

Should We Administer Ativan (Lorazepam)?

No, do not routinely administer Ativan to a patient who is not eating, barely drinking, and speaking minimally without first determining the underlying cause and specific symptoms requiring treatment. This clinical presentation demands careful assessment before benzodiazepine administration, as lorazepam may worsen certain conditions and carries significant risks in vulnerable patients.

Critical Assessment First

Before considering lorazepam, you must determine:

• Is this delirium? If the patient has altered mental status, confusion, or fluctuating consciousness, benzodiazepines can worsen delirium and should be avoided 1. Neuroleptics like haloperidol or levomepromazine are the appropriate first-line agents for delirium, not benzodiazepines 1.

• Is this end-of-life care? If the patient has refractory symptoms at end of life (intractable pain, dyspnea, agitation despite optimal treatment), then benzodiazepines may be appropriate as part of palliative sedation 1.

• Is this anxiety or dyspnea? Benzodiazepines have a role in treating anxiety and dyspnea when other measures fail 2, but only after addressing reversible causes.

When Lorazepam May Be Appropriate

For refractory dyspnea: Low-dose lorazepam titrated to respiratory distress can provide anxiolysis when opioids alone are insufficient 2. Start with minimal doses and titrate carefully.

For refractory anxiety at end of life: When anxiety is causing suffering and other interventions have failed, lorazepam may be used as part of symptom management 1.

For palliative sedation: In the context of refractory symptoms at end of life, benzodiazepines like midazolam (preferred) or lorazepam can be used, typically starting at 0.5-1 mg/hour for midazolam or equivalent dosing for lorazepam 1.

Critical Warnings Against Routine Use

The FDA label explicitly warns about multiple serious risks 3:

• Respiratory depression risk: Extreme caution required in elderly, very ill patients, or those with limited pulmonary reserve due to risk of hypoventilation and hypoxic cardiac arrest 3
• Paradoxical reactions: Can cause paradoxical agitation, especially in elderly patients 1, 3
• Oversedation and confusion: Particularly problematic in elderly patients, can cause pseudodementia, amnestic disorders, and ataxia 4
• Propylene glycol toxicity: Risk with higher doses, especially in renal impairment 3

Common Pitfalls to Avoid

1. Do not give lorazepam for presumed anxiety when delirium is present - This is a critical error that worsens outcomes. The distinction between anxiety and delirium is essential because benzodiazepines worsen delirium 1.

2. Do not use in elderly patients without extreme caution - A retrospective study of 20 elderly patients showed common side effects including oversedation, confusion, depression, and drug-induced pseudodementia 4.

3. Do not assume the patient needs sedation - The presentation of not eating, barely drinking, and minimal speech could represent depression, delirium, severe illness, or end-of-life transition. Each requires different management.

Appropriate Clinical Algorithm

Step 1: Assess for delirium (confusion, altered consciousness, fluctuating symptoms)

• If present → Use neuroleptics (haloperidol, levomepromazine), NOT benzodiazepines 1

Step 2: If end-of-life care, identify specific refractory symptoms

• Dyspnea → Optimize positioning, oxygen if indicated, opioids first, then consider low-dose benzodiazepines for anxiolysis 2
• Refractory agitation → Consider palliative sedation protocol with appropriate monitoring 1

Step 3: If administering lorazepam is deemed necessary:

• Start with lowest effective dose (0.5-2 mg) 3
• Have resuscitative equipment immediately available 3
• Monitor vital signs continuously
• Reduce dose by 50% if patient has hepatic disease or is on probenecid/valproate 3

Step 4: Continue pain medications if previously prescribed - do not discontinue opioids when starting sedation unless signs of overdose present 1

The clinical context you describe warrants thorough evaluation before reflexively administering any sedative medication. The risks of benzodiazepines in this vulnerable population often outweigh benefits unless specific indications are clearly identified.